Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

BeiGene Q1 2024 GAAP EPADS $(2.41) Beats $(2.89) Estimate, Sales $751.652M Beat $676.451M Estimate

Author: Benzinga Newsdesk | May 08, 2024 06:10am

BeiGene (NASDAQ:BGNE) reported quarterly losses of $(2.41) per share which beat the analyst consensus estimate of $(2.89) by 16.61 percent. This is a 27.84 percent increase over losses of $(3.34) per share from the same period last year. The company reported quarterly sales of $751.652 million which beat the analyst consensus estimate of $676.451 million by 11.12 percent. This is a 67.85 percent increase over sales of $447.801 million the same period last year.

Posted In: BGNE